SGSylvia Garza-Manero

Sylvia Garza-Manero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sylvia Garza-Manero has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perspective Chapter: The Role of Long Non-Coding RNAs in X Chromosome Dosage Compensation

    by Sylvia Garza-Manero, Hober Nelson Núñez-Martínez, Gustavo Tapia-Urzúa, Félix Recillas-Targa

    Genetic sex determination required the specialization of an ancestral autosome pair into sexual chromosomes. This evolutionary trajectory involves recombination suppression in the sexual pair and degeneration of one chromosome. In species with a male XY heterogametic system, the Y chromosome is highly degenerated, creating a difference in the dosage of X-linked genes between females and males. To overcome this difference, one X chromosome is transcriptionally silenced in female mammals. Conversely, genes on the single-male X chromosome of lizards and the fruit fly are overexpressed, reaching the transcriptional output produced by two X chromosomes in females. Despite promoting opposite effects on transcription, these dosage compensation mechanisms share relevant features, including the modification of the chromatin landscape and three-dimensional conformation orchestrated, at least in part, by long non-coding RNAs transcribed from the target X. In this chapter, we describe the mechanisms of X chromosome dosage compensation in eutherians, marsupials, Drosophila, and a lizard. We focus on the leading role of the respective long non-coding RNA, XIST in eutherians, RSX in marsupials, roX1 and roX2 in the fruit fly, and the recently described MAYEX in lizards, in the ambitious task of equalizing the transcriptional output of X-linked genes between females and males.

  • Open Access

    A Bidirectional Non-Coding RNA Promoter Mediates Long-Range Gene Expression Regulation

    by Carlos Alberto Peralta-Alvarez, Hober Nelson Núñez-Martínez, Ángel Josué Cerecedo-Castillo, Augusto César Poot-Hernández, Gustavo Tapia-Urzúa, Sylvia Garza-Manero, Georgina Guerrero, Félix Recillas-Targa

    Recent evidence suggests that human gene promoters display gene expression regulatory mechanisms beyond the typical single gene local transcription modulation. In mammalian genomes, genes with an associated bidirectional promoter are abundant; bidirectional promoter architecture serves as a regulatory hub for a gene pair expression. However, it has been suggested that its contribution to transcriptional regulation might exceed local transcription initiation modulation. Despite their abundance, the functional consequences of bidirectional promoter architecture remain largely unexplored. This work studies the long-range gene expression regulatory role of a long non-coding RNA gene promoter using chromosome conformation capture methods. We found that this particular bidirectional promoter contributes to distal gene expression regulation in a target-specific manner by establishing promoter–promoter interactions. In particular, we validated that the promoter–promoter interactions of this regulatory element with the promoter of distal gene BBX contribute to modulating the transcription rate of this gene; removing the bidirectional promoter from its genomic context leads to a rearrangement of BBX promoter–enhancer interactions and to increased gene expression. Moreover, long-range regulatory functionality is not directly dependent on its associated non-coding gene pair expression levels.


  • Open Access

    Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva

    by Brandon Bustos-Garcia, Sylvia Garza-Manero, Nallely Cano-Dominguez, Dulce Maria Lopez-Sanchez, Gonzalo Salgado-Montes de Oca, Alfonso Salgado-Aguayo, Felix Recillas-Targa, Santiago Avila-Rios, Victor Julian Valdes

    Massive testing is a cornerstone in efforts to effectively track infections and stop COVID-19 transmission, including places with good vaccination coverage. However, SARS-CoV-2 testing by RT-qPCR requires specialized personnel, protection equipment, commercial kits, and dedicated facilities, which represent significant challenges for massive testing in resource-limited settings. It is therefore important to develop testing protocols that are inexpensive, fast, and sufficiently sensitive. Here, we optimized the composition of a buffer (PKTP), containing a protease, a detergent, and an RNase inhibitor, which is compatible with the RT-qPCR chemistry, allowing for direct SARS-CoV-2 detection from saliva without extracting RNA. PKTP is compatible with heat inactivation, reducing the biohazard risk of handling samples. We assessed the PKTP buffer performance in comparison to the RNA-extraction-based protocol of the US Centers for Disease Control and Prevention in saliva samples from 70 COVID-19 patients finding a good sensitivity (85.7% for the N1 and 87.1% for the N2 target) and correlations (R = 0.77, p < 0.001 for N1, and R = 0.78, p < 0.001 for N2). We also propose an auto-collection protocol for saliva samples and a multiplex reaction to minimize the PCR reaction number per patient and further reduce costs and processing time of several samples, while maintaining diagnostic standards in favor of massive testing.